Binding molecules for cancer treatment

The present invention relates to binding molecules that specifically bind to CD137 and FAP and their use in pharmaceuticals, pharmaceutical compositions containing the binding molecules and methods of using the binding molecules as agents for the treatment and/or prevention of cancer. 本发明涉及特异性结合于CD1...

Full description

Saved in:
Bibliographic Details
Main Authors LOWE DAVID C, BOGUS EDGAR, SCHOLL JASON M, TILAP IRIS, TUMMOND JAMES R, GUPTA PIYUSH, SCHAUBNY ANDREAS
Format Patent
LanguageChinese
English
Published 09.06.2023
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to binding molecules that specifically bind to CD137 and FAP and their use in pharmaceuticals, pharmaceutical compositions containing the binding molecules and methods of using the binding molecules as agents for the treatment and/or prevention of cancer. 本发明涉及特异性结合于CD137及FAP的结合分子及其在药物中的用途、含有所述结合分子的药物组合物及使用所述结合分子作为治疗和/或预防癌症的药剂的方法。
Bibliography:Application Number: CN202180035724